Al's Comment:

 This is an interesting example of how advances against glioblastoma may come from **combining treatments rather than continually searching for a single “magic bullet.”** Researchers are studying whether extracellular vesicles – tiny particles that can cross the blood-brain barrier – can make glioblastoma cells more vulnerable to CAR T-cell therapy. They are using mathematical modeling and sophisticated image analysis to understand exactly how the two interact.

 

I particularly like the multidisciplinary nature of this project. Biology, immunology, physics, mathematics and computer programming are all being brought together to attack the same problem. The researchers are even developing software to analyze hundreds of microscope images and quantify how extracellular vesicles are being absorbed by tumor cells and how that affects CAR T-cell killing.

 

Of course, this is still early laboratory research and is a long way from proving that the combination will help patients. But glioblastoma has defeated many promising single treatments. Finding ways to intelligently combine therapies – and using computational tools to determine which combinations actually work synergistically – may be one of our best paths toward meaningful progress.

 

Battleship of Experiments: The Fight Against Brain Cancer